Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chromosome Translocation”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Post-approval studies (Phase 4)Study completedNCT01061177
What this trial is testing

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Who this might be right for
CML in Chronic Phase
Novartis Pharmaceuticals 1,090
Early research (Phase 1)Study completedNCT00422825
What this trial is testing

Effect of Food on Bioavailability of a Modified Release Formulation of Imatinib

Who this might be right for
Healthy
Novartis Pharmaceuticals 16
Large-scale testing (Phase 3)Study completedNCT01254188
What this trial is testing

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 421
Testing effectiveness (Phase 2)Study completedNCT00261846
What this trial is testing

Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias

Who this might be right for
Chronic Myeloid Leukemia
Pfizer 571
Testing effectiveness (Phase 2)Ended earlyNCT01392170
What this trial is testing

Pegasys in Patients With Chronic Myeloid Leukemia (CML)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 2
Not applicableStudy completedNCT05216068
What this trial is testing

Investigation and Diagnosis of the Chromosome Variation in Donated/abandoned Blastocyst

Who this might be right for
Chromosome TranslocationGenetic Disorders in PregnancyRecurrent Miscarriage
Chang Gung Memorial Hospital 57
Large-scale testing (Phase 3)Active Not RecruitingNCT04971226
What this trial is testing

Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP

Who this might be right for
Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
Novartis Pharmaceuticals 405
Testing effectiveness (Phase 2)Looking for participantsNCT05442515
What this trial is testing

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

Who this might be right for
B-NHLB-Non Hodgkin LymphomaAcute Lymphocytic Leukemia+8 more
National Cancer Institute (NCI) 126
Not applicableStudy completedNCT07174804
What this trial is testing

Chromosomal Translocations in Chandigarh Police

Who this might be right for
Chromosomal Translocations
Post Graduate Institute of Medical Education and Research, Chandigarh 203
Post-approval studies (Phase 4)Study completedNCT01243489
What this trial is testing

Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND Optimisation

Who this might be right for
Chronic Myelogenous Leukemia (CML)
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 104
Not applicableStudy completedNCT02451761
What this trial is testing

Apparently Balanced Chromosomal Translocation/ Next-generation Sequencing/ Intellectual Disability

Who this might be right for
Intellectual DisabilityCongenital Abnormalities
Hospices Civils de Lyon 55
Testing effectiveness (Phase 2)WithdrawnNCT04845035
What this trial is testing

Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
University of Michigan Rogel Cancer Center
Large-scale testing (Phase 3)Study completedNCT02130557
What this trial is testing

Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive
Pfizer 536
Testing effectiveness (Phase 2)Study completedNCT01058434
What this trial is testing

Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Novartis Pharmaceuticals 43
Early research (Phase 1)Study completedNCT01460498
What this trial is testing

Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 3
Post-approval studies (Phase 4)UnknownNCT01990807
What this trial is testing

Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia

Who this might be right for
Childhood Acute Lymphoblastic LeukemiaPhiladelphia Chromosome, Ph^1^, AbsentB-cell Childhood Acute Lymphoblastic Leukemia
Chinese Academy of Medical Sciences 20
Testing effectiveness (Phase 2)Study completedNCT00171223
What this trial is testing

An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Novartis Pharmaceuticals 532
Testing effectiveness (Phase 2)Study completedNCT00171249
What this trial is testing

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia

Who this might be right for
Philadelphia Positive Chronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Novartis Pharmaceuticals 293
Testing effectiveness (Phase 2)Study completedNCT00852566
What this trial is testing

Randomized Study Comparing the Effect of Dasatinib and Imatinib on Malignant Stem Cells in Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Norwegian University of Science and Technology 46
Testing effectiveness (Phase 2)Study completedNCT00171158
What this trial is testing

An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis

Who this might be right for
Philadelphia Chromosome Positive CML
Novartis Pharmaceuticals 260
Load More Results